Moderna vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?

Moderna is leveraging its mRNA platform to expand beyond COVID-19 vaccines into RSV and oncology therapeutics. Vertex Pharmaceuticals maintains market dominance in cystic fibrosis while successfully ...
tradingkey

Vertex Pharmaceuticals Inc Stock (VRTX) Moved Down by 3.13% on Oct 13: What Investors Need To Know

Vertex faced downward price pressure from biotech sector weakness and technical selling.Core fundamentals remain supported by ...

Global Chromosomal Microarray Reflex Testing Market Report 2026-2030 | Capitalize on 9.1% CAGR as Thermo Fisher, LabCorp, Illumina, Agilent, and Natera Scale Precision Genomics

Dublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- "Chromosomal Microarray Reflex Testing Global Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global chromosomal microarray ...
Rare Disease Advisor

Innovative Oxford-Harrington Partnership Amplifies Rare Disease Research Funding

The partnership has already brought in more than $200 million in philanthropic donations to help fund specific rare disease ...
BIOENGINEER

Tiny Antennae on Bile Duct Cells Emerge as Master Sensors of Liver Health and Disease

A new review in Nature Reviews Gastroenterology & Hepatology explains how cholangiocyte primary cilia sense bile flow, ...